PPP
GILD icon

Private Portfolio Partners’s Gilead Sciences GILD Stock Holding History

Private Portfolio Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,890
Closed -$290K – 202
2020
Q1 		$290K Buy
3,890
+547
+16% +$37.8K 0.15% 139
2019
Q4 		$217K Buy
3,343
+1
+0% +$65 0.09% 190
2019
Q3 		$212K Sell
3,342
-78
-2% -$5.1K 0.1% 184
2019
Q2 		$231K Buy
+3,420
New +$225K 0.1% 199

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Private Portfolio Partners's GILD Position: Q2 2020 in Review

Private Portfolio Partners sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 3,890 shares — an estimated $290K sold.

Private Portfolio Partners first reported a position in GILD in Q2 2019 and held it in 4 quarters. The position peaked at $290K in Q1 2020. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Private Portfolio Partners reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Private Portfolio Partners sold 3,890 Gilead Sciences shares in Q2 2020, an estimated $290K.
  • Private Portfolio Partners first reported a position in Gilead Sciences in Q2 2019 and held it in 4 quarters.
  • Private Portfolio Partners's Gilead Sciences position peaked at $290K in Q1 2020.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Private Portfolio Partners's 13F filing for Q2 2020, filed 14 Aug 2020.